My SNMMI Overview

My Organizations
My Councils
My Committees

Search results

Add
Skip to search results
Data pager
Data pager
Page size:
PageSizeComboBox
select
 143 items in 10 pages
Show all 143
 
Data pager
Data pager
Page size:
PageSizeComboBox
select
 143 items in 10 pages
Show all 143
Content Icon
Jun 16, 2026 – A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP) is safe and effective for patients, according to a new study published in the June issue of JNM.
Content Icon
Jun 2, 2026 – A novel theranostic approach that targets RET—a newly identified biomarker for neuroendocrine prostate cancer— enables high-contrast PET imaging and effective, safe treatment for this highly aggressive malignancy.
Content Icon
Oct 8, 2024 –
Content Icon
Mar 30, 2026 – The goal of this recommendation is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of brain PET imaging that depicts tau aggregation in the brain (referred to as tau PET hereafter). This r
Content Icon
Jul 6, 2026 – A bill that would establish licensure for medical imaging and radiation therapy professionals, including for nuclear medicine technology, has passed the Pennsylvania Senate.
Content Icon
Jul 8, 2026 – The Society of Nuclear Medicine and Molecular Imaging (SNMMI) mourns the passing of George S. Sgouros, PhD, an internationally recognized medical physicist whose work helped transform the field of radiopharmaceutical therapy.
Content Icon
Jul 8, 2026 –
Content Icon
Jul 8, 2026 –
Content Icon
Jul 8, 2026 –
Content Icon
Jul 8, 2026 –
Content Icon
Jul 8, 2026 –